Literature DB >> 1090359

Long-term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy.

D Berd, J Cornog, R C DeConti, M Levitt, J R Bertino.   

Abstract

Seventeen patients with Stage III or IV reticulum cell sarcoma were treated with three cycles of a 5-drug regimen between February, 1969 and December, 1970. Of the 17 patients, 9 attained a complete remission and 6 had a parital remission; 2 were considered unevaluable. Recently, the original biopsies from these patients were reclassified according to the criteria of rappaport et al. The results were: diffuse histiocytic--8; nodular histiocytic--2; diffuse mixed--2; nodular mixed--3; diffuse lymphocytic poorly differentiated--1; nodular lymphocytic poorly differentiated--1. Of the 8 patients with diffuse histiocytic lymphoma 6 attained complete remission, 1 had a partial remission, and 1 was unevaluable. One of the 6 with complete remission relapsed at 7 months and died 2 months later. However, the other 5 are alive and in continued unmaintained remission for 55 to 65 months.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1090359     DOI: 10.1002/1097-0142(197504)35:4<1050::aid-cncr2820350406>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 2.  Oncostatic-antibody complexes in chemotherapy.

Authors:  H F Dullens; R A De Weger
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Non-Hodgkin's lymphoma of bone causing avascular necrosis of the femoral head.

Authors:  S Renowden; E J Fitzgerald; A M Kemp
Journal:  Postgrad Med J       Date:  1988-01       Impact factor: 2.401

4.  Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.

Authors:  H S Dhaliwal; A Z Rohatiner; W Gregory; M A Richards; P W Johnson; J S Whelan; C J Gallagher; J Matthews; T S Ganesan; M J Barnett
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

5.  Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification.

Authors:  R C Leonard; J Cuzick; I C MacLennan; R I Vanhegan; P H Mackie; C V McCormick
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.